Tackling Mpox: Global Regulators Call For Larger Trials And Coordinated Pathways

International regulators want developers of new mpox vaccines to consider alternatives to placebo-controlled studies when these are not feasible, such as the use of animal models and immunobridging studies.

(Shutterstock)

Regulators around the world have stressed the need for larger clinical trials and a more coordinated approach to tackle the ongoing mpox public health emergency. This year saw cases being reported from 80 countries, including the US, where the first case of the clade I strain of mpox was reported on 15 November.

More from Vaccines

More from Geography